APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum.

The sigma-1 receptor (Sig1R) is an endoplasmic reticulum chaperonin that is attracting tremendous interest as a potential anti-neurodegenerative target. While this membrane protein is known to reside in the inner nuclear envelope (NE) and influences transcription, apparent Sig1R presence in the nucleoplasm is often observed, seemingly contradicting its NE localization. We addressed this confounding issue by applying an antibody-free approach of electron microscopy (EM) to define Sig1R nuclear localization. We expressed APEX2 peroxidase fused to Sig1R-GFP in a Sig1R-null NSC34 neuronal cell line generated with CRISPR-Cas9. APEX2-catalyzed gold/silver precipitation markedly improved EM clarity and confirmed an apparent intra-nuclear presence of Sig1R. However, serial sectioning combined with APEX2-enhanced EM revealed that Sig1R actually resided in the nucleoplasmic reticulum (NR), a specialized nuclear compartment formed via NE invagination into the nucleoplasm. NR cross-sections also indicated Sig1R in ring-shaped NR membranes. Thus, this study distinguishes Sig1R in the NR which could otherwise appear localized in the nucleoplasm if detected with low-resolution methods. Our finding is important for uncovering potential Sig1R regulations in the nucleus.

[1]  Laura Trinkle-Mulcahy,et al.  Faculty Opinions recommendation of Directed evolution of APEX2 for electron microscopy and proximity labeling. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[2]  H. Kiyama,et al.  Mitochondria‐associated membrane collapse is a common pathomechanism in SIGMAR1‐ and SOD1‐linked ALS , 2016, EMBO molecular medicine.

[3]  Sylvia B. Smith,et al.  Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration , 2016, Proceedings of the National Academy of Sciences.

[4]  Geunsik Lee,et al.  APEX Fingerprinting Reveals the Subcellular Localization of Proteins of Interest. , 2016, Cell reports.

[5]  Bess Frost,et al.  Alzheimer's disease: An acquired neurodegenerative laminopathy , 2016, Nucleus.

[6]  Shang-Yi Tsai,et al.  The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems. , 2016, Trends in pharmacological sciences.

[7]  A. Bonci,et al.  Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope , 2015, Proceedings of the National Academy of Sciences.

[8]  C. McCurdy,et al.  The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes , 2015, EBioMedicine.

[9]  C. Futter,et al.  Photoreceptor phagosome processing defects and disturbed autophagy in retinal pigment epithelium of Cln3Δex1-6 mice modelling juvenile neuronal ceroid lipofuscinosis (Batten disease) , 2015, Human molecular genetics.

[10]  H. Hirano,et al.  Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus , 2015, Nature.

[11]  T. Mavlyutov,et al.  Subcellular Localization of the Sigma-1 Receptor in Retinal Neurons — an Electron Microscopy Study , 2015, Scientific Reports.

[12]  H. Hara,et al.  Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage. , 2015, Experimental eye research.

[13]  K. Wakabayashi,et al.  Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease , 2015, Neurobiology of Disease.

[14]  T. Mavlyutov,et al.  Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS) , 2015, Journal of pharmacological sciences.

[15]  K. Muir,et al.  Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke , 2014, Stroke.

[16]  T. Wieloch,et al.  Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. , 2014, Brain : a journal of neurology.

[17]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[18]  A. Kakita,et al.  Accumulation of the sigma‐1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases , 2014, Neuropathology : official journal of the Japanese Society of Neuropathology.

[19]  J. Borge-Holthoefer,et al.  Sigma receptor 1 modulates ER stress and Bcl2 in murine retina , 2014, Cell and Tissue Research.

[20]  Nidhi Kaushal,et al.  Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects. , 2014, Advances in pharmacology.

[21]  T. Mavlyutov,et al.  Lack of sigma-1 receptor exacerbates ALS progression in mice , 2013, Neuroscience.

[22]  B. Winblad,et al.  Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models , 2013, Proceedings of the National Academy of Sciences.

[23]  D. Rossi,et al.  Sigma receptor modulators: a patent review , 2013, Expert opinion on therapeutic patents.

[24]  S. Kourrich,et al.  Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine , 2013, Cell.

[25]  P. Liu,et al.  Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N′-dimethyltryptamine forming enzyme, indole-N-methyl transferase , 2012, Neuroscience.

[26]  F. Al-Mohanna,et al.  A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis , 2011, Annals of neurology.

[27]  D. Vaux,et al.  The nucleoplasmic reticulum: form and function. , 2011, Trends in cell biology.

[28]  R. Nickells,et al.  Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor , 2011, Molecular vision.

[29]  S. Buch,et al.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator. , 2010, Trends in pharmacological sciences.

[30]  T. Mavlyutov,et al.  The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study , 2010, Neuroscience.

[31]  K. Hashimoto,et al.  Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors , 2010, Annals of general psychiatry.

[32]  M. Jackson,et al.  The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.

[33]  V. Ganapathy,et al.  In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. , 2008, Investigative ophthalmology & visual science.

[34]  K. Hashimoto,et al.  High Occupancy of Sigma-1 Receptors in the Human Brain after Single Oral Administration of Fluvoxamine: A Positron Emission Tomography Study Using [11C]SA4503 , 2007, Biological Psychiatry.

[35]  A. Ruoho,et al.  Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. , 2007, Protein expression and purification.

[36]  V. Ganapathy,et al.  Expression, subcellular localization, and regulation of sigma receptor in retinal muller cells. , 2006, Investigative ophthalmology & visual science.

[37]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.